CEO: Lee Berger, MD

The “Ortho-tag” system consists of an implantable “tag” or “wearable device” and touch probe. This innovation improves the secure transmission of wireless communication with implantable devices through transcutaneous volume conduction – not through the air like traditional RFID, but through the electrical conductivity of biological tissues –  and enables health care providers the ability to securely program, reprogram, and obtain real-time access (directly from the patient) to vital in-body information.


Go to Website